2021 (Gyo-Ke) 10069 [PTH-Containing Agent for Treating/Preventing Osteoporosis] <Kanno>
更新日：3 日前
Article information
Article type: Case note
Category: Patents
Topics: Inventive step
First published on this website: 2026-11-01
Display and classification checked: November 2, 2026
Originally published on Ameblo: 2024-12-07 (Japan time). Full English translation.
2021 (Gyo-Ke) 10069 [PTH-Containing Agent for Treating/Preventing Osteoporosis] <Kanno>
*Remarkable effects denied ⇒ Inventive step not satisfied
“The defendant argues that, if the fracture-suppressing effect in patients satisfying the three conditions is statistically significant compared with placebo, while that in patients not satisfying the three conditions is not, it can immediately be said that the osteoporosis treatment of Invention 1 has a superior effect in patients satisfying the three conditions.
However, absence of statistical significance merely means that it is unclear whether the effect is superior; it does not immediately mean that the effect is not superior. Nor can it be excluded that the absence of significance results from an insufficient number of cases.”
Update history
The first-published date remains unchanged. Display maintenance, classification changes, related-article updates, and text corrections are recorded separately.
November 1, 2026: First published on this website.
November 2, 2026: Added article information, classification, topics, language navigation, related articles where the same case was confirmed, consultation guidance, and SEO. The original text and first-published date were preserved.
